‎Counterfeit Ozempic and Wegovy on the Rise: 4 Expert-Backed Ways to Avoid Dangerous Fake Weight Loss Drugs

Two years after GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound became household names, the demand has only intensified. Originally developed to treat type 2 diabetes, these medications quickly became popular for their substantial weight loss effects. Recent data from KFF Health Tracking reveals that one in eight adults in the U.S. has tried a GLP-1 medication, reflecting just how mainstream these drugs have become.

‎

Fake Ozempic and Wegovy are flooding the market as demand skyrockets.

‎Michael Siluk/UCG/Universal Images Group via Getty Images

‎

‎Escalating demand has opened the floodgates for dangerous counterfeits. The World Health Organization (WHO) issued a global alert in response to the growing infiltration of fake versions of GLP-1 drugs. Pharmaceutical companies Eli Lilly and Novo Nordisk have responded with lawsuits targeting entities responsible for distributing these fraudulent medications.

‎

‎The scarcity of authentic products has driven patients toward alternative providers. “As soon as these drugs hit the market, the demand was so high that pharmacies began running out of them,” notes Dr. Supriya Rao of Integrated Gastroenterology Consultants in Boston. This supply void has been increasingly filled by medical spas and compounding pharmacies that operate outside of U.S. Food and Drug Administration (FDA) oversight.

‎

‎Medications prepared by compounding pharmacies are not identical to FDA-approved versions. Dr. Carolyn Jasik, chief medical officer at Omada Health, emphasizes that compounded GLP-1 drugs lack standardized safety and efficacy. “These medications are essentially ‘copies’ of approved drugs but without the same regulatory safeguards,” she explains.

‎

‎What’s more alarming is the proliferation of outright counterfeit drugs masquerading as legitimate GLP-1 medications. These fakes often contain the wrong dosage, entirely incorrect ingredients, or no active ingredient at all. “Counterfeit drugs, no matter what, are dangerous and can lead to serious health consequences,” Jasik warns.

‎

‎The health risks are not theoretical. Patients have reported side effects such as nausea, irregular blood sugar levels, and infections at injection sites. Adverse reactions become even more likely when the drug source is unclear or unverified.

‎

‎Price is another major driver pushing consumers toward illegitimate sources. Many GLP-1 drugs remain out of reach due to their high cost. “We’re in a moment where access is being dictated by availability and affordability,” says Jasik. The lack of insurance coverage in some cases further complicates access, increasing the temptation to buy from cheaper, unregulated sources.

‎

‎To reduce the risk of encountering counterfeit GLP-1s, pharmacists and health professionals advise consumers to adopt a few precautionary steps:

‎

‎1. Purchase Only from Licensed Pharmacies

‎

‎Obtaining GLP-1 medications from state-licensed pharmacies or FDA-registered facilities is a vital first defense. “Avoid purchasing any medication from social media promotions or unauthorized online sources,” advises Simona Dorf, PharmD, clinical pharmacist at First Databank.

‎

‎2. Verify Online Sources Thoroughly

‎

‎The FDA’s BeSafeRx initiative offers tools to help consumers identify licensed online pharmacies and recognize red flags. Always verify your prescription with a licensed medical provider before proceeding with any online purchase.

‎

‎3. Examine Packaging Closely

‎

‎Small details can help identify fakes. Misspellings, faded text, or unfamiliar branding on packaging are immediate causes for concern. Consumers should also cross-reference serial and lot numbers using the FDA’s online resources.

‎

‎4. Steer Clear of Compounding Pharmacies for GLP-1s

‎

‎Unless explicitly directed by your healthcare provider, avoid compounded versions of semaglutide medications. “Who knows what you’re injecting from one day to the next?” Dr. Rao cautions. “The lack of consistency makes this a risky approach.”

‎

‎Medical experts continue to urge patients to focus on a broader, safer approach to weight loss that includes consistent self-monitoring, healthy eating, exercise, and structured lifestyle habits. Jasik reinforces the importance of discussing any weight-loss drug use with a qualified healthcare provider to ensure safety and effectiveness.